内部人交易记录
其他基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Pfeiffenberger Brent. Officer active across 3 companies, notably Century Therapeutics, Inc.. Cumulatively, 24 reports have been logged. Split: 2 buys · 6 sells. Total volume traded: €96k. Activity tracked since 4 December 2023. The latest transaction was disclosed on 11 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Pfeiffenberger Brent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
13,850 股@ US$1.94Common StockSEC:0002001162-26-000018:0
463 股@ US$2.110.0003% mcap0.1% 占其流量Common StockSEC:0002001162-26-000016:0
31,172 股@ US$1.920.017% mcap7.9% 占其流量Common StockSEC:0002001162-26-000014:0
13,849 股Common StockSEC:0002001162-26-000012:0
463 股@ US$2.130.0002% mcap0.2% 占其流量Common StockSEC:0002001162-26-000010:0
7,500 股0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234813:0
55,397 股@ US$2.7321.4% 占其流量Common StockSEC:0002001162-26-000006:0
463 股@ US$2.560.2% 占其流量Common StockSEC:0002001162-26-000004:0
31,172 股@ US$1.757.6% 占其流量Common StockSEC:0001104659-26-017132:0
475,000 股0Common StockSEC:0002001162-26-000002:0
52,000 股@ US$0.58376.0% 占其流量Common StockSEC:0002001162-25-000009:0
463 股@ US$0.5260.1% 占其流量Common StockSEC:0002001162-25-000007:0
35,000 股@ US$0.49513.7% 占其流量Common StockSEC:0002001162-25-000005:0
32,456 股@ US$0.4543.1% 占其流量Common StockSEC:0002001162-25-000003:0
488 股@ US$0.500.1% 占其流量Common StockSEC:0001062993-25-015525:0
1,587,614 股0Common StockSEC:0001062993-25-014562:0
475 股@ US$0.6220.1% 占其流量Common StockSEC:0001062993-25-011427:0
29,552 股@ US$0.5463.8% 占其流量Common StockSEC:0001062993-25-009868:0
2,235 股@ US$0.6150.3% 占其流量Common StockSEC:0001062993-25-005292:0
34,712 股@ US$0.7836.9% 占其流量Common StockSEC:0001062993-25-003043:0
243,447 股@ US$1.4488.9% 占其流量Common StockSEC:0001062993-24-020202:0
17,425 股0Common StockSEC:0001062993-24-006667:0
17,425 股0Common StockSEC:0001062993-24-006184:0
1,173,775 股0Common StockSEC:0001062993-23-022023:0
About Pfeiffenberger Brent
Pfeiffenberger Brent is an executive at Century Therapeutics, Inc., where he is President and CEO, at Corbus Pharmaceuticals Holdings, Inc., where he is a Director, and at Butterfly Network, Inc., where he is President and CEO. He has 21 filings in total, and across the 21 sampled recent filings, the buy and sell amounts are EUR 40818 and EUR 54755, with filings ranging from 2023-12-06 to 2026-06-15.